A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co‑morbid substance use disorders
about
The complicated relationship between attention deficit/hyperactivity disorder and substance use disordersImpulsive choice and environmental enrichment: effects of d-amphetamine and methylphenidateMethylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).Sharing and selling of prescription medications in a college student sample.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?A clinical approach to the assessment and management of co-morbid eating disorders and substance use disordersPilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trialAttenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeysProspective relationships of ADHD symptoms with developing substance use in a population-derived sample.Short-acting versus Long-acting Medications for the Treatment of ADHDA review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.Questioning the specificity of ASRS-v1.1 to accurately detect ADHD in substance abusing populations.Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system?Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder.Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects.The association between smoking prevalence and eating disorders: a systematic review and meta-analysis.Gene expression profiling in the striatum of amphetamine-treated spontaneously hypertensive rats which showed amphetamine conditioned place preference and self-administration.Oral methylphenidate establishes a conditioned place preference in ratsStroop task among patients with obsessive-compulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT).Reduction of bulimia nervosa symptoms after psychostimulant initiation in patients with comorbid ADHD: five case reports.Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD.The patient's perspective on the link between ADHD and substance use: a qualitative interview study.Interaction between methylphenidate, methadone and different antidepressant drugs on antinociception in mice, and possible clinical implications.Psychostimulant treatment of combat-related posttraumatic stress disorder.Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment.
P2860
Q26851607-DF37B808-8D25-40D8-82F5-22A70FF67778Q30489660-5DFF5B8C-40C5-4B48-A111-6164CBCF52FAQ30498578-E900AE4F-CE22-4696-BE8E-4733176F0762Q30582194-FCCBC42E-0E1B-4941-B406-A81F9076214AQ33755090-5157A4C3-C8C8-4963-B7DB-4FE983334E9CQ33919950-8951591A-E448-44D8-A81D-7FE2AB2F4858Q34481587-A44C8C48-A0D2-4A89-A9B4-1D2C030ECEB7Q35875805-1E7D9DC4-1511-4EF4-AE21-EF105A0B0B3BQ36818345-4E2ABECE-699F-4F1A-BB46-A65FF0833037Q37001184-42801A40-AD3A-4D8B-9F05-BC7F124BBFC3Q37225845-1084BC0A-29D6-4052-96B2-7BC5A8EF667EQ37638740-06FA82BF-94CC-420B-B6DC-3B89FFEF96A7Q37952196-BA126147-3C9A-401E-9ED1-12BE4B29606DQ38016975-E119DD87-F555-40CB-9451-A4F82758BF61Q38223307-0BC18A01-F94B-4C3B-8EE1-CE1699C35653Q38248567-C01CA1F4-ABBE-4C72-9703-273054A7EC73Q38840137-110C461B-BEE5-4BE0-9939-8CF2D6E4BCCCQ39138814-4CA06DB6-B164-4517-817E-91AD7C2F27A3Q41483014-25A1E9A0-FB8D-457A-AE4E-521995D35075Q43871084-2C40B461-F42D-466B-9DDC-82B811D4EF14Q43921798-399D6E59-AB0D-4C94-8E6D-B55929ADD4F8Q44973697-9703A7A9-08AC-40DD-8331-7A915CED3595Q45449797-B45F655A-E992-4281-85F3-DBFFC4C525FEQ47366011-52E3DCAB-8F7E-45BA-A4FB-46F96F455E92Q49013090-6568D342-9075-4481-AF28-552DF1AB6633Q52301191-004B05AA-CEB8-4D55-B60E-545256D2D807
P2860
A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co‑morbid substance use disorders
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A qualitative review of issues ...... morbid substance use disorders
@ast
A qualitative review of issues ...... morbid substance use disorders
@en
A qualitative review of issues ...... morbid substance use disorders
@en-gb
A qualitative review of issues ...... morbid substance use disorders
@nl
type
label
A qualitative review of issues ...... morbid substance use disorders
@ast
A qualitative review of issues ...... morbid substance use disorders
@en
A qualitative review of issues ...... morbid substance use disorders
@en-gb
A qualitative review of issues ...... morbid substance use disorders
@nl
altLabel
A qualitative review of issues ...... morbid substance use disorders
@en
prefLabel
A qualitative review of issues ...... morbid substance use disorders
@ast
A qualitative review of issues ...... morbid substance use disorders
@en
A qualitative review of issues ...... morbid substance use disorders
@en-gb
A qualitative review of issues ...... morbid substance use disorders
@nl
P356
P1476
A qualitative review of issues ...... morbid substance use disorders
@en
P2093
Scott H. Kollins
P304
P356
10.1185/030079908X280707
P407
P577
2008-04-01T00:00:00Z